Annual report pursuant to Section 13 and 15(d)

Debt - Mortgage Notes And Other Debt (Details)

v2.4.1.9
Debt - Mortgage Notes And Other Debt (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Dec. 31, 2013
Mortgage notes and other debt payables    
Current portion of notes payable $ 13,455us-gaap_LongTermDebtCurrent [1] $ 12,562us-gaap_LongTermDebtCurrent [1]
Other long-term liabilities 2,434us-gaap_LongTermDebtNoncurrent 3,270us-gaap_LongTermDebtNoncurrent
OPKO Health Europe    
Mortgage notes and other debt payables    
Current portion of notes payable 608us-gaap_LongTermDebtCurrent
/ us-gaap_BusinessAcquisitionAxis
= opk_OPKOHealthEuropeMember
1,964us-gaap_LongTermDebtCurrent
/ us-gaap_BusinessAcquisitionAxis
= opk_OPKOHealthEuropeMember
Other long-term liabilities 2,435us-gaap_LongTermDebtNoncurrent
/ us-gaap_BusinessAcquisitionAxis
= opk_OPKOHealthEuropeMember
3,270us-gaap_LongTermDebtNoncurrent
/ us-gaap_BusinessAcquisitionAxis
= opk_OPKOHealthEuropeMember
Total mortgage notes and other debt $ 3,043us-gaap_LongTermDebt
/ us-gaap_BusinessAcquisitionAxis
= opk_OPKOHealthEuropeMember
$ 5,234us-gaap_LongTermDebt
/ us-gaap_BusinessAcquisitionAxis
= opk_OPKOHealthEuropeMember
[1] As of December 31, 2014 and December 31, 2013, total assets include $7.6 million and $6.7 million, respectively, and total liabilities include $12.1 million and $10.4 million, respectively, related to SciVac, previously known as SciGen (I.L.) Ltd, a consolidated variable interest entity. SciVac’s consolidated assets are owned by SciVac and SciVac’s consolidated liabilities have no recourse against us. Refer to Note 4.